NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-118-2021-0-US-02 Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors US National Stage 18/567,990 Pending
NIAID E-137-2025-0-US-01 ZIKA VIRUSES AND USES THEREOF US 63/607,147 Expired
NCI E-082-2023-0-PC-01 LIGANDS SPECIFIC FOR ASCT1 PCT PCT PCT/EP2023/084599 Expired
NHLBI E-239-2023-1-US-01 Prazoles as potential broad spectrum anti-viral agents US 63/606,812 Expired
NCATS E-091-2016-0-IN-01 COMPOUNDS AND METHOD FOR BLOCKING TRANSMISSION OF MALARIAL PARASITE IN DIV 202318083229 Abandoned
NCI E-099-2014-0-JP-02 MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF JP DIV 2023-205633 Pending
NCI E-101-2021-0-AU-04 T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 AU National Stage 2022268998 Pending
NIDA E-053-2023-0-PCT-01 FLUORINATED MU-OPIOID RECEPTOR AGONISTS PCT PCT PCT/US2023/082355 Expired
NCI E-142-2022-0-PC-01 Topoisomerase Ill (TOP3) inhibitors and antiviral compounds based on bisacridines PCT PCT PCT/US2023/082186 Expired
NIAID E-080-2013-0-HK-01 Attenuation of Human Respiratory Syncytial Virus by Genome Scale Codon-Pair Deoptimization HK EP 42023083593.6 Pending
NCI E-101-2021-0-KR-06 T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 KR National Stage 10-2023-7041691 Pending
NIAID E-026-2024-0-US-01 Broadly neutralizing influenza hemagglutinin stem-directed antibodies US 63/605,374 Expired
NCI E-171-2018-9-US-08 MODIFIED CELLS AND METHODS OF THERAPY US REEXAM 90/019,313 11583556 Issued PDF
NCI E-183-2017-0-US-02 ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS US CON 18/524,799 Pending
NIAAA E-087-2021-0-EP-01 A FACILE AND ODOR-FREE APPROACH TO CONVERT UREA/SULFONYL UREA TO CHALCOGENIDE UREA/ SULFONYL UREA EP National Stage 22729881.7 Pending
NIAID E-131-2020-8-US-01 Anti-Coronavirus Antibodies And Methods Of Use US DIV 18/524,940 Pending
NHGRI E-044-2013-1-AU-01 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA AU DIV 2023274161 Pending
NCI E-027-2022-0-PC-01 TOPOISOMERASE Ill (TOP3) INHIBITORS AND ANTIVIRAL COMPOUNDS BASED ON CYANINES PCT PCT PCT/US2023/081638 Expired
NIAID E-028-2024-0-PC-01 PEPTIDES AND PEPTIDE MICROARRAYS FOR DETECTION AND DIFFERENTIATION OF ANTIBODY RESPONSES TO EBOLA VIRUS PCT PCT PCT/US2023/081625 Expired
NCI E-173-2020-0-HK-01 T CELL RECEPTORS RECOGNIZING R273C OR Y220C MUTATIONS IN P53 HK EP 62023083439.7 Pending
NEI E-156-2023-0-US-01 MODIFIED PIGMENT EPITHELIUM-DERIVED FACTOR PEPTIDES AND METHODS OF USE US 63/604,026 Expired
NEI E-153-2020-0-CA-04 Biodegradable Tissue Scaffold With Secondary Matrix To Host Weakly Adherent Cells CA National Stage 3220433 Pending
NCI E-046-2019-1-US-01 HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS US CON 18/520,027 Pending
NEI E-155-2020-0-JP-06 METHODS TO GENERATE MACULAR, CENTRAL AND PERIPHERAL RETINAL PIGMENT EPITHELIAL CELLS JP National Stage 2023-572794 Pending
NEI E-153-2020-0-JP-05 BIODEGRADABLE TISSUE SCAFFOLD WITH SECONDARY MATRIX TO HOST WEAKLY ADHERENT CELLS JP National Stage 2023-572792 Pending
NIAID E-221-2022-2-KR-01 LENTIVIRAL VECTORS USEFUL FOR THE TREATMENT OF DISEASE KR National Stage 10-2023-7040650 Pending
NIDDK E-112-2021-0-US-02 VITAMIN C RENAL LEAK AS A CLINICAL DIAGNOSTIC TOOL IN THE DETECTION, MONITORING, AND MANAGEMENT OF ACUTE AND CHRONIC DISEASES US National Stage 18/563,663 Pending
NHLBI E-127-2021-2-CN-01 COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASES CN National Stage 202280037094.2 Pending
NCI E-171-2018-7-EP-01 MODIFIED CELLS AND METHODS OF THERAPY EP DIV 23211577.4 Pending
NCI E-174-2018-2-EP-01 TUMOR INFILTRATING LYMPHOCYTES AND METHODS OF THERAPY EP DIV 23211578.2 Pending
NCI E-101-2021-0-EP-08 T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 EP National Stage 22726335.7 Pending
NIDA E-046-2024-0-US-01 DEVELOPMENT OF ANTI-OPIOID VACCINES US 63/601,913 Expired
NICHD E-028-2020-0-US-02 TAMPERLESS TENSOR ELASTOGRAPHY IMAGING US National Stage 18/563,237 Pending
NEI E-155-2020-0-US-02 METHODS TO GENERATE MACULAR, CENTRAL AND PERIPHERAL RETINAL PIGMENT EPITHELIAL CELLS US National Stage 18/562,806 Pending
NCI E-191-2019-0-EP-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH Q61K MUTATION EP National Stage 22721599.3 Pending
NEI E-155-2020-0-CA-05 METHODS TO GENERATE MACULAR, CENTRAL AND PERIPHERAL RETINAL PIGMENT EPITHELIAL CELLS CA National Stage 3220602 Pending
NCI E-027-2023-0-PC-01 REAL-TIME REMOTE CONTROLLED MICROSCOPY AND COMMUNICATIONS OVER A NETWORK PCT PCT PCT/US2023/079836 Expired
NIAAA E-087-2021-0-US-02 A FACILE AND ODOR-FREE APPROACH TO CONVERT SULFONYL UREA DERIVATIVES TO CHALCOGENIDE SULFONYL UREA DERIVATIVES US National Stage 18/561,068 Pending
NCI E-228-2023-0-US-01 Tixocortol Pivalate for use in the prevention and/or treatment of SARS-CoV-2 infections US 63/599,446 Expired
NCI E-239-2017-0-NZ-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST MUTATED RAS NZ DIV 805541 Pending
NCI E-065-2021-0-CN-01 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS DESIGNED TO REDUCE RETROVIRAL RECOMBINATION AND USES THEREOF CN National Stage 202280034971.0 Pending
NCI E-096-2021-0-US-02 LABELING BIOLOGICAL PARTICLES USING ACOUSTOPHORESIS US National Stage 18/290,442 Pending
NEI E-153-2020-0-US-02 Biodegradable Tissue Scaffold With Secondary Matrix To Host Weakly Adherent Cells US National Stage 18/290,396 Pending
NCI E-219-2022-0-US-02 CIRCULATING miRNA MARKERS FOR DETECTION OF RADIATION EXPOSURE US ORD 18/507,575 Pending
NCATS E-039-2021-0-JP-01 METHODS AND SYSTEMS FOR SOLID PHASE EXTRACTION JP National Stage 2023-557052 Pending
NCI E-264-2011-0-US-02 DELIVERY OF PACKAGED RNA TO MAMMALIAN CELLS US CON 18/507,690 Abandoned
NINDS E-018-2024-0-PCT-01 ANGUBINDIN-1 TREATMENT AGAINST MALIGNANT GLIOMA PCT PCT PCT/US2023/079547 Pending
NIA E-062-2021-0-EP-01 HUMAN INSULIN C-ALPHA-PEPTIDES AND METHODS OF USE EP National Stage 22722061.3 Pending
NCATS E-204-2022-5-US-01 MULTI-CYCLC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US 63/598,011 Expired
NEI E-155-2020-0-AU-01 METHODS TO GENERATE MACULAR, CENTRAL AND PERIPHERAL RETINAL PIGMENT EPITHELIAL CELLS AU National Stage 2022280062 Pending